| tüüp : |
ajaleht |
| interneti link : |
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=4147 |
|
| uurimisrühmad : |
Columbus - The Ohio State University Hospitals, Department of Pharmacy |
| Autor : |
Nahata M C. |
| pealkiri : |
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. |
| publikatsioon : |
Int J Pharm Compound ; 30, 3 : 247-249. 2016 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
ingredientide nimekiri
 Morphine sulfate
|
 |
 |
 |
 |
0,2 mg
® = Morphine elixir (Roxane laboratories) |
| destilleeritud vesi |
>> 1 ml |
|
25°C |
 |
| 60 |
 |
|
|
|
|
Sildenafil citrate
|
 |
|
 |
 |
75 mg
Revatio® |
| OraPlus® / OraSweet® (1:1) |
>>30 ml |
|
25°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| Lihtsiirup |
21 ml |
| Metüültselluloos |
1% 3 ml |
|
25°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| OraPlus® / OraSweet® (1:1) |
>>30 ml |
|
4°C |
|
| 91 |
|
|
|
|
|
|
75 mg
Revatio® |
| Lihtsiirup |
21 ml |
| Metüültselluloos |
1% 3 ml |
|
4°C |
|
| 91 |
|
|
|
|
|
